Gelesis Holdings, Inc. (GLSHQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 5, 2026
Gelesis Holdings Revenue
Gelesis Holdings had revenue of $1.11M in the quarter ending June 30, 2023, a decrease of -87.66%. This brings the company's revenue in the last twelve months to $12.14M, down -45.79% year-over-year. In the year 2022, Gelesis Holdings had annual revenue of $25.77M with 130.37% growth.
Revenue (ttm)
12.14M
Revenue Growth
-45.79%
P/S Ratio
0.00
Revenue / Employee
130.54K
Employees
93
Market Cap
73.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Athersys | 80.00K |
| American Oriental Bioengineering | 121.58M |
| Genocea Biosciences | 1.91M |
| Infinity Pharmaceuticals | 2.57M |
| Panacos Pharmaceuticals | 99.00K |
| Baudax Bio | 1.27M |
| RVL Pharmaceuticals | 36.92M |
| Core One Labs | 338.91K |
Gelesis Holdings News
- 3 years ago - Gelesis Holdings Earnings Call Transcript: Q4 2022 - Transcripts
- 3 years ago - Gelesis Holdings Earnings Call Transcript: Q3 2022 - Transcripts
- 4 years ago - Gelesis Holdings Earnings Call Transcript: Q2 2022 - Transcripts